DRUGBANK_ID,DRUG_GROUPS,JCHEM_RULE_OF_FIVE,JCHEM_PHYSIOLOGICAL_CHARGE,GENERIC_NAME,JCHEM_BIOAVAILABILITY,ALOGPS_LOGP
DB08569,experimental,1,1,"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",1,4.16
DB07107,experimental,1,1,(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,1,3.12
DB04060,experimental,1,-2,"(5-Methyl-6-Oxo-1,6-Dihydro-Pyridin-3-Yl)-1,2-Dideoxy-Ribofuranose-5-Monophosphate",1,-0.82
DB12964,investigational,1,1,Lerisetron,1,3.01
DB11878,investigational,0,-1,Filibuvir,1,5.13
DB08503,experimental,1,0,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",1,-0.33
DB08500,experimental,1,0,"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",1,0.14
DB04865,approved; investigational,0,1,Omacetaxine mepesuccinate,0,2.09
